Growth characteristics and imaging properties of the Morris hepatoma 3924A in ACI rats:: A suitable model for transarterial chemoembolization

被引:48
作者
Trübenbach, J [1 ]
Graepler, F [1 ]
Pereira, PL [1 ]
Ruck, P [1 ]
Lauer, U [1 ]
Gregor, M [1 ]
Claussen, CD [1 ]
Huppert, PE [1 ]
机构
[1] Univ Hosp Tubingen, Dept Diagnost Radiol, D-72076 Tubingen, Germany
关键词
hepatoma; animal model; transarterial chemoembolization; angiography; ultrasound; magnetic resonance imaging; computed tomography;
D O I
10.1007/s002700010045
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Purpose: For experimental studies investigating modalities and efficacy of transarterial chemoembolization (TACE) in hepatocellular carcinoma (HCC) an animal model resembling the human situation as closely as possible would be appropriate, Specifically, reproducible turner growth characteristics with the capability for appropriate in vivo imagine to monitor treatment efficacy are required. Methods: Morris hepatoma 3924A was implanted into the liver of 30 ACI rats. Tumor growth was followed by angiography (n = 10), ultrasound (US, II = 30), native computed tomography (CT, n = 16), and native magnetic resonance imaging (MRI, n = 30) between day 8 and day 36 after implantation. The radiological morphological characteristics were compared with the macroscopic and microscopic histological findings of the explanted tumors. Results: In all 30 animals a solitary liver tumor was found and macroscopically no signs of metastases, ascites, or peritoneal tumor were visible. On histopathological examination tumor sizes ranged between 27 +/- 3 mm(3) (day 8) and 3468 +/- 79 mm(3) (day 36). The first signs of tumor necrosis occurred at day 16, US allowed tumor visualization from day 8, MRI from day 8, angiography from day 10, and CT from day 14. Conclusions: The tumor model has the potential to be used for the visualization of tumor growth by MRI and US. The potential for monitoring therapeutic effects of TACE needs to be investigated.
引用
收藏
页码:211 / 217
页数:7
相关论文
共 24 条
[1]
EXPERIMENTS ON THE EFFICACY AND TOXICITY OF LOCOREGIONAL CHEMOTHERAPY OF LIVER-TUMORS WITH 5-FLUORO-2'-DEOXYURIDINE (FUDR) AND 5-FLUOROURACIL (5-FU) IN AN ANIMAL-MODEL [J].
BARTKOWSKI, R ;
BERGER, MR ;
AGUIAR, JLA ;
HENNE, TH ;
DORSAM, J ;
GEELHAAR, GH ;
SCHLAG, P ;
HERFARTH, C .
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1986, 111 (01) :42-46
[2]
BURGENER FA, 1980, CANCER, V46, P56, DOI 10.1002/1097-0142(19800701)46:1<56::AID-CNCR2820460113>3.0.CO
[3]
2-C
[4]
ESTIMATION OF LIVER-TUMOR VOLUME USING DIFFERENT FORMULAS - AN EXPERIMENTAL-STUDY IN RATS [J].
CARLSSON, G ;
GULLBERG, B ;
HAFSTROM, L .
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1983, 105 (01) :20-23
[5]
DESANTIS M, 1993, J COMPUT ASSIST TOMO, V17, P901
[6]
DUMAS O, 1990, GASTROEN CLIN BIOL, V14, P715
[7]
PATTERNS OF CONTRAST ENHANCEMENT OF BENIGN AND MALIGNANT HEPATIC NEOPLASMS DURING BOLUS DYNAMIC AND DELAYED CT [J].
FREENY, PC ;
MARKS, WM .
RADIOLOGY, 1986, 160 (03) :613-618
[8]
A LIVER-TUMOR MODEL IN THE RAT SUITABLE FOR EXPERIMENTAL MRT [J].
HAMM, B ;
TAUPITZ, M .
FORTSCHRITTE AUF DEM GEBIETE DER RONTGENSTRAHLEN UND DER NEUEN BILDGEBENDEN VERFAHREN, 1993, 158 (04) :332-336
[9]
CHEMOEMBOLIZATION OF HEPATOCELLULAR-CARCINOMA - CT FINDINGS AND CLINICAL-RESULTS IN PROSPECTIVE REPETITIVE THERAPY [J].
HUPPERT, PE ;
GEISSLER, F ;
DUDA, SH ;
LAUCHART, W ;
DETTE, S ;
DIETZ, K ;
BRAMBS, HJ ;
CLAUSSEN, CD .
FORTSCHRITTE AUF DEM GEBIETE DER RONTGENSTRAHLEN UND DER NEUEN BILDGEBENDEN VERFAHREN, 1994, 160 (05) :425-432
[10]
PROSPECTIVE AND RANDOMIZED CLINICAL-TRIAL FOR THE TREATMENT OF HEPATOCELLULAR-CARCINOMA - A COMPARISON OF LIPIODOL-TRANSCATHETER ARTERIAL EMBOLIZATION WITH AND WITHOUT ADRIAMYCIN (1ST COOPERATIVE STUDY) [J].
KAWAI, S ;
OKAMURA, J ;
OGAWA, M ;
OHASHI, Y ;
TANI, M ;
INOUE, J ;
KAWARADA, Y ;
KUSANO, M ;
KUBO, Y ;
KURODA, C ;
SAKATA, Y ;
SHIMAMURA, Y ;
JINNO, K ;
TAKAHASHI, A ;
TAKAYASU, K ;
TAMURA, K ;
NAGASUE, N ;
NAKANISHI, Y ;
MAKINO, M ;
MASUZAWA, M ;
MIKURIYA, S ;
MONDEN, M ;
YUMOTO, Y ;
MORI, T ;
ODA, T .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1992, 31 :S1-S6